Sentence: These data suggest that weekly docetaxel plus carboplatin may be an important therapeutic second-line treatment option for patients with DRPC .
Drug combination annotation:
[{'class': 'POS', 'spans': ['docetaxel', 'carboplatin'], 'is_context_needed': False}]